Evaluation of the potential carcinogenicity of benz(a)anthracene. Final report

Technical Report · Wed Jun 01 00:00:00 EDT 1988

OSTI ID:6521468

Benz(a)anthracene is a probable human carcinogen, classified as weight-of-evidence Group B2 under the EPA Guidelines for Carcinogen Risk Assessment. Evidence on potential carcinogenicity from animal studies is Sufficient, and the evidence from human studies is No Data. The potency factor (F) for benz(a)anthracene is estimated to be 21.1/(mg/kg/day), placing it in potency group 2 according to the CAG's methodology for evaluating potential carcinogens. Combining the weight-of-evidence group and the potency group, benz(a)anthracene is assigned a MEDIUM hazard ranking for the purposes of RQ adjustment.

• Research Organization: Syracuse Research Corp., NY (United States)
• OSTI ID: 6521468
• Report Number(s): PB-93-184935/XAB; CNN: EPA-68-03-3112; EPA-68-03-3182
• Country of Publication: United States
• Language: English

Related Subjects

29 ENERGY PLANNING, POLICY, AND ECONOMY
290300 -- Energy Planning & Policy-- Environment
Health
& Safety
560300* -- Chemicals Metabolism & Toxicology
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
ANIMALS
ANTHRACENE
AROMATICS
CARCINOGENS
CONDENSED AROMATICS
DATA PROCESSING
DOCUMENT TYPES
DOSE-RESPONSE RELATIONSHIPS
HAZARDOUS MATERIALS
HUMAN POPULATIONS
HYDROCARBONS
MATERIALS
NATIONAL ORGANIZATIONS
ORGANIC COMPOUNDS
POPULATIONS
PROCESSING
REGULATORY GUIDES
RISK ASSESSMENT
TASK SCHEDULING
TOXICITY
US EPA
US ORGANIZATIONS
WEIGHT